Visual Loss after Platelet-rich Plasma Injection into the Face

References

• Cohen S, Dover J, Monheit G, et al. Five-year safety and satisfaction study of PMMA-collagen in the correction of nasolabial folds. Dermatol Surg. 2015 Dec;41(Suppl 1):S302–13. doi:10.1097/DSS.0000000000000542.
   PubMed Web of Science ®Google Scholar
• Joseph JH. The case for synthetic injectables. Facial Plast Surg Clin North Am. 2015 Nov;23(4):433–445. doi:10.1016/j.fsc.2015.07.003.
   PubMed Web of Science ®Google Scholar
• Daines SM, Williams EF. Complications associated with injectable soft-tissue fillers: a 5-year retrospective review. JAMA Facial Plast Surg. 2013 May;15(3):226–231. doi:10.1001/jamafacial.2013.798.
   PubMed Web of Science ®Google Scholar
• Golberg RA, Fiaschetti D. Filling the periorbital hollow with hyaluronic acd gel: initial experience with 244 injections. Opthalmic Plast Reconstr Surg. 2006 Sep–Oct;22(5):335–341. doi:10.1097/01.iop.0000235820.00633.61.
   PubMed Web of Science ®Google Scholar
• Hirsch RJ, Stier M. Complications of soft tissue augmentation. J Drugs Dermatol. 2008 Sep;7(9):841–845.
   PubMedGoogle Scholar
• Kassir R, Kolluru A, Kassir M. Extensive necrosis after injection of hyaluronic acid filler: case report and review of the literature. J Cosmet Dermatol. 2011 Sep;10(3):224–231. doi:10.1111/jcd.2011.10.issue-3.
   PubMed Web of Science ®Google Scholar
• Park SW, Woo SJ, Park KH, Huh JW, Jung C, Kwon OK. Iatrogenic retinal artery occlusion caused by cosmetic facial filler injections. Am J Ophthalmol. 2012;154:653–662. doi:10.1016/j.ajo.2012.04.019.
   PubMed Web of Science ®Google Scholar
• Carruthers JD, Fagien S, Rohrich RJ, Weinkle S, Carruthers A. Blindness caused by cosmetic filler injection: a review of cause and therapy. Plast Reconstr Surg. 2014 Dec;134(6):1197–1201. doi:10.1097/PRS.0000000000000754.
   PubMed Web of Science ®Google Scholar
• Kim YK, Jung C, Wood SJ, Park KH. Cerebral angiographic findings of cosmetic facial filler related ophthalmic and retinal artery occlusion. J Korean Med Sci. 2015 Dec;30(12):1846–1855. doi:10.3346/jkms.2015.30.12.1847.
   Web of Science ®Google Scholar
• Paap MK, Milman T, Ugradar S, Goldberg R, Silkiss RZ. Examining the role of retrobulbar hyaluronidase in reversing filler- induced blindness: a systematic review. Ophthalmic Plast Reconstr Surg. 2019 Dec 24. In Press.
   PubMed Web of Science ®Google Scholar
• Mehryan P, Zartab H, Rajabi A, Pazhoohi N, Firooz A. Assessment of efficacy of platelet-rich plasma (PRP) on infraorbital dark circles and crow’s feet wrinkles. J Cosmet Dermatol. 2014 Mar;13(1):72–78. doi:10.1111/jocd.2014.13.issue-1.
   PubMed Web of Science ®Google Scholar
• Sclafani AP. Platelet-rich fibrin matrix for improvement of deep nasolabial folds. J Cosmet Dermatol. 2010 Mar;9(1):66–71. doi:10.1111/jcd.2010.9.issue-1.
   PubMed Web of Science ®Google Scholar
• Ramos-Torrecillas J, De Luna-Bertos E, García-Martínez O, Ruiz C. Clinical utility of growth factors and platelet-rich plasma in tissue regeneration: a review. Wounds. 2014 July;26(7):207–213.
   PubMed Web of Science ®Google Scholar
• Dohan Ehrenfest DM, Andia I, Zumstein MA, Zhang CQ, Pinto NR, Bielecki T. Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J. 2014 May 8;4(1):3–9. doi:10.32098/mltj.01.2014.02.
   PubMedGoogle Scholar
• Anitua E, Muruzabal F, Tayebba A, et al. Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies. Acta Ophthalmol. 2015 Dec;93(8):e605–14. doi:10.1111/aos.12710.
   PubMed Web of Science ®Google Scholar
• Figueroa MS, Govetto A, Arriba-Palomero PD. Short-term results of platelet-rich plasma as adjuvant to 23-G vitrectomy in the treatment of high myopic macular holes. Eur J Ophthalmol. 2016 Aug 4;26(5):491–496. doi:10.5301/ejo.5000729.
   PubMed Web of Science ®Google Scholar
• Martinez-Gonzalez JM, Cano-Sanchez JGonzalo-Lafuente JC, Campo-Trapero J, Esparza-Gomez G, Seoane J. Do ambulatory-use Platelet-Rich Plasma (PRP) concentrates present risks? Med Oral. 2002 Nov-Dec;7(5):375–390.
   PubMedGoogle Scholar
• Bosetti M, Boffano P, Marchetti A, Leigheb M, Colli M, Brucoli M. The number of platelets in patient’s blood influences the mechanical and morphological properties of PRP-clot and lysophosphatidic acid quantity in PRP. Int J Mol Sci. 2019 Dec 24;21(1):E139:1–13. doi:10.3390/ijms21010139.
   PubMed Web of Science ®Google Scholar
• Carle MV, Roe R, Novack R, Boyer DS. Cosmetic facial fillers and severe vision loss. JAMA Opthalmol. 2014 May;132(5):637–639. doi:10.1001/jamaophthalmol.2014.498.
   PubMed Web of Science ®Google Scholar
• Daicker BC, Kreuzer G. Acquired black disc and melanotic retina after resection of an orbital meningioma. Klin Monbl Augenheilkd. 1981 Nov;179(5):322–329. doi:10.1055/s-2008-1057321.
   PubMed Web of Science ®Google Scholar
• Kang BK, Kang IJ, Jeong KH, Shin MK. Treatment of glabella skin necrosis injection of hyaluronic acid usind platelet rich plasma. J Cosmet Laser Ther. 2016;18(2):111–112. doi:10.3109/14764172.2015.1052512.
   PubMed Web of Science ®Google Scholar
• Kalyam K, Kavoussi SC, Ehrlich M, et al. Irreversible blindness following periocular autologous platelet-rich plasma skin rejuvenation treatment. Ophthal Plast Reconstr Surg. 2017 May/June;33(3S Suppl 1):S12–S16. doi:10.1097/IOP.0000000000000680.
   PubMed Web of Science ®Google Scholar
• Lee W, Koh IS, Oh W, Yang EJ. Ocular complications of soft tissue filler injections: a review of literature. J Cosmet Dermatol. 2019 Nov 11. doi:10.1111/jocd.13213.
   Web of Science ®Google Scholar
• Humzah MD, Ataullah S, Chiang C, Malthora R, Golberg R. The treatment of hyaluronic acid aesthetic interventional induced visual loss (AIIVL): a consensus on practical guidance. J Cosmet Dermatol. 2019 Feb;18(1):71–76. doi:10.1111/jocd.12672.
   PubMed Web of Science ®Google Scholar